Billiontoone Q1 Earnings Call Highlights
Billiontoone (NASDAQ:BLLN) reported first-quarter 2026 results showing rapid revenue growth alongside GAAP profitability, driven by higher test volumes, rising average selling prices (ASPs), and expanding gross margins. Management also highlighted the launch of a new prenatal confirmation offering, additional payer contracting progress, and ongoing product development milestones in oncology. Quarterly results: revenue up 84% with […]
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.